A carregar...
Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
PURPOSE: To develop a population pharmacokinetic (PK) model for cabazitaxel in patients with advanced solid tumors and examine the influence of demographic and baseline parameters. METHODS: One hundred and seventy patients who received cabazitaxel (10–30 mg/m(2), 1-h IV infusion) every 7 or 21 days...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer-Verlag
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3579428/ https://ncbi.nlm.nih.gov/pubmed/23299792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-012-2058-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|